Pfizer’s drug succeeds in late-stage blood cancer trial
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Pfizer said on Tuesday a combination treatment using its drug, Adcetris, met the main goal of a late-stage study of extending survival in patients with a type of blood cancer.
:max_bytes(150000):strip_icc():format(jpeg)/FPM-Best-Personal-Loans-Methodology-Recirc-468fcab5bfa84ae485bd56843cf5c0eb.png "How We Review and Rate Personal Loan Lenders")
:max_bytes(150000):strip_icc():format(jpeg)/PropertyValuation-4ecdfe3a87144fe998087ef433f49c13.jpeg "Is There a Gender Gap in Home Equity Loans?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1346781100-2724c28da6b2479b88db9d1337ebe926.jpg "Buy Now, Pay Later or Rent-to-Own: Which Is the Smarter Way to Pay for Purchases?")